Management of advanced prostate cancer

被引:6
|
作者
Kaliks, Rafael A.
Del Giglio, Auro
机构
[1] Hematology and Oncology Center for Studies and Research, ABC School of Medicine, SP
[2] Santo André - SP 09060-650
来源
关键词
prostatic neoplasms/therapy; hormones/therapeutic use; hormonal antineoplastic agents; drug therapy; epidemiology;
D O I
10.1590/S0104-42302008000200025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Geriatricians and general practitioners often follow patients with metastatic prostate cancer, The epidemiology and basic treatment principles of metastatic prostate cancer are discussed aiming to update the topic for the non-oncologist. Hormone manipulation remains the basis of treatment, usually up to a second line of therapy. Selected cases are treated successfully with intermittent androgen ablation, When new hormone-independent clones arise, chemotherapy should be added to therapy that confers improved survival as well as better quality of life when based on taxanes. In specific situations, additional measures such as bisphosphonates and radiation therapy should be included in the treatment. As a rule, the public health system makes available the necessary medication to ensure treatment for the vast majority of patients in Brazil.
引用
收藏
页码:178 / 182
页数:5
相关论文
共 50 条
  • [41] Radiation therapy in the management of locally advanced prostate cancer
    Michalski J.M.
    Current Urology Reports, 2006, 7 (3) : 217 - 224
  • [42] BASIS FOR HORMONAL MANAGEMENT OF ADVANCED PROSTATE-CANCER
    GELLER, J
    CANCER, 1993, 71 (03) : 1039 - 1045
  • [43] Management strategies for patients with locally advanced prostate cancer
    Gospodarowicz, M
    Bolla, M
    Di Silverio, F
    Gibbons, R
    Mendoza, A
    Prezioso, D
    Schulze, H
    Soloway, M
    Solsona, E
    Van Poppel, H
    Porter, A
    McAninch, J
    PROSTATE CANCER, 2000, : 327 - 349
  • [44] Use of transdermal estrogen in the management of advanced prostate cancer
    Cafferty, Fay H.
    Langley, Ruth E.
    Abel, Paul D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (02) : 279 - 279
  • [45] Preventive management of bone disease in advanced prostate cancer
    Rosino-Sanchez, Antonio
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (03): : 258 - 266
  • [46] Contemporary Management of Advanced Prostate Cancer: An Evolving Landscape
    Khanna, Abhinav
    O'Connor, Luke P.
    Murthy, Prithvi B.
    Bryk, Darren J.
    Fascelli, Michele
    Ericson, Kyle
    Yerram, Nitin K.
    Haywood, Samuel C.
    Abouassaly, Robert
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 108 - 118
  • [47] Critical appraisal of cabazitaxel in the management of advanced prostate cancer
    Pal, Sumanta Kumar
    Twardowski, Przemyslaw
    Sartor, Oliver
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 395 - 402
  • [48] Current management of advanced and castration resistant prostate cancer
    Gomella, Leonard G.
    Petrylak, Daniel P.
    Shayegan, Bobby
    CANADIAN JOURNAL OF UROLOGY, 2014, 21 : 1 - 6
  • [49] Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
    Gillessen, Silke
    Turco, Fabio
    Davis, Ian D.
    Efstathiou, Jason A.
    Fizazi, Karim
    James, Nicholas D.
    Shore, Neal
    Small, Eric
    Smith, Matthew
    Sweeney, Christopher J.
    Tombal, Bertrand
    Zilli, Thomas
    Agarwal, Neeraj
    Antonarakis, Emmanuel S.
    Aparicio, Ana
    Armstrong, Andrew J.
    Bastos, Diogo Assed
    Attard, Gerhardt
    Axcrona, Karol
    Ayadi, Mouna
    Beltran, Himisha
    Bjartell, Anders
    Blanchard, Pierre
    Bourlon, Maria T.
    Briganti, Alberto
    Bulbul, Muhammad
    Buttigliero, Consuelo
    Caffo, Orazio
    Castellano, Daniel
    Castro, Elena
    Cheng, Heather H.
    Chi, Kim N.
    Clarke, Caroline S.
    Clarke, Noel
    De Bono, Johann S.
    De Santis, Maria
    Duran, Ignacio
    Efstathiou, Eleni
    Ekeke, Onyeanunam N.
    El Nahas, Tamer I. H.
    Emmett, Louise
    Fanti, Stefano
    Fatiregun, Omolara A.
    Feng, Felix Y.
    Fong, Peter C. C.
    Fonteyne, Valerie
    Fossati, Nicola
    George, Daniel J.
    Gleave, Martin E.
    Gravis, Gwenaelle
    EUROPEAN UROLOGY, 2025, 87 (02) : 157 - 216
  • [50] Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
    Gillessen, S.
    Omlin, A.
    Attard, G.
    de Bono, J. S.
    Efstathiou, E.
    Fizazi, K.
    Halabi, S.
    Nelson, P. S.
    Sartor, O.
    Smith, M. R.
    Soule, H. R.
    Akaza, H.
    Beer, T. M.
    Beltran, H.
    Chinnaiyan, A. M.
    Daugaard, G.
    Davis, I. D.
    De Santis, M.
    Drake, C. G.
    Eeles, R. A.
    Fanti, S.
    Gleave, M. E.
    Heidenreich, A.
    Hussain, M.
    James, N. D.
    Lecouvet, F. E.
    Logothetis, C. J.
    Mastris, K.
    Nilsson, S.
    Oh, W. K.
    Olmos, D.
    Padhani, A. R.
    Parker, C.
    Rubin, M. A.
    Schalken, J. A.
    Scher, H. I.
    Sella, A.
    Shore, N. D.
    Small, E. J.
    Sternberg, C. N.
    Suzuki, H.
    Sweeney, C. J.
    Tannock, I. F.
    Tombal, B.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1589 - 1604